Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Bajaj Finserv Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesDivi's Laboratories Limited8.40574393628.4573
Domestic EquitiesSun Pharmaceutical Industries Limited8.236115223427.8832
Domestic EquitiesApollo Hospitals Enterprise Limited5.92712735520.0663
Domestic EquitiesAurobindo Pharma Limited5.537215281818.7462
Domestic EquitiesCipla Limited5.061911191117.1369
Domestic EquitiesPiramal Pharma Limited4.397979531614.8891
Domestic EquitiesNeuland Laboratories Limited4.2583833914.4165
Domestic EquitiesBiocon Limited3.995533956813.5267
Domestic EquitiesEmcure Pharmaceuticals Limited3.42578200211.5975
Domestic EquitiesFortis Healthcare Limited3.262712018311.0460
Domestic EquitiesRubicon Research Limited2.47251276328.3707
Domestic EquitiesLupin Limited2.2312362787.5538
Domestic EquitiesIPCA Laboratories Limited2.1668504837.3357
Domestic EquitiesGlenmark Pharmaceuticals Limited2.0501356636.9407
Domestic EquitiesPfizer Limited1.9565133146.6237
Domestic EquitiesSanofi Consumer Healthcare India Limited1.9081138636.4597
Domestic EquitiesShaily Engineering Plastics Limited1.9068248096.4553
Domestic EquitiesVijaya Diagnostic Centre Limited1.8195617186.1598
Domestic EquitiesZydus Wellness Limited1.75341379055.9361
Domestic EquitiesGodrej Consumer Products Limited1.6919500005.7280
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Limited1.5898209475.3823
Domestic EquitiesDr. Lal Path Labs Limited1.5881176185.3767
Domestic EquitiesAbbott India Limited1.544017385.2270
Domestic EquitiesMedi Assist Healthcare Services Limited1.41121005904.7775
Domestic EquitiesMedPlus Health Services Limited1.2340516524.1776
Domestic EquitiesMax Healthcare Institute Limited1.2021350004.0698
Domestic EquitiesRainbow Childrens Medicare Limited1.1776295033.9867
Domestic EquitiesHindustan Unilever Limited1.1352155813.8432
Domestic EquitiesTorrent Pharmaceuticals Limited1.1348103263.8419
Domestic EquitiesJubilant Pharmova Limited1.1261349863.8124
Domestic EquitiesAlembic Pharmaceuticals Limited1.0704399473.6240
Domestic EquitiesSyngene International Limited1.0559551393.5747
Domestic EquitiesTata Consumer Products Limited1.0389300003.5172
Domestic EquitiesEmami Limited1.0151647823.4367
Domestic EquitiesMankind Pharma Limited0.9658145263.2698
Domestic EquitiesAstraZeneca Pharma India Limited0.870832672.9481
Domestic EquitiesEternal Limited0.7756875002.6259
Domestic EquitiesMarico Limited0.6694315922.2664
Total 93.0698 315.0873
Cash & Cash Equivalents and Net AssetsClearing Corporation of India Ltd4.3425 14.7014
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)-1.0378 -3.5134
Total 3.3047 11.1880
Derivatives-FuturesAurobindo Pharma Limited December 2025 Future2.1379588507.2380
Total 2.1379 7.2380
Domestic Mutual Funds UnitsBajaj Finserv Money Market Fund-Direct Plan-Growth1.4875421965.0361
Total 1.4875 5.0361
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.